Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 7 signals
Share change
+90,905,207
Put/Call ratio
16%
SEC-reported price per share
$2.31
Number of holders
147
Value change
+$211,768,578
Number of buys
90
Open additional details 1 more signal available
Number of sells
53
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
285,714,286

Security key

877619106

Report period

Q2 2025

Institutions

147

Top holders

10

Ownership snapshot

Top reported holders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Paul B. Manning
Disclosed value leader
Paul B. Manning
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 3/4/5 13F Lead comparable stake: 9.8% 13D/G row: Paul B. Manning Showing 1-6 of 15 holder rows.

Quick read

Paul B. Manning leads the comparable SEC ownership view at 9.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Paul B. Manning's linked filing trail.
Comparable ownership Top 5
Paul B. Manning 9.8%
MORGAN STANLEY 6.7%
GOLDMAN SACHS GROUP INC 5.1%
Avoro Capital Advisors LLC 7%
RTW INVESTMENTS, LP 6.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Paul B. Manning
13D/G 3/4/5
10%+ Owner
9.8%
$59,394,578
25,601,111 shares
$0 30 May 2025
MORGAN STANLEY
13D/G 13F
Company
6.7%
$44,506,820
16,858,644 shares
-$2,034,437 30 Jun 2025
GOLDMAN SACHS GROUP INC
13D/G 13F
THE GOLDMAN SACHS GROUP, INC. · Company
5.1%
$33,274,806
12,748,968 shares
$0 26 Jun 2025
Avoro Capital Advisors LLC
13F
Company
13F
7%
$27,799,999
19,999,999 shares
31 Mar 2025
RTW INVESTMENTS, LP
13F
Company
13F
6.6%
$26,115,134
18,787,866 shares
31 Mar 2025
FMR LLC
13F
Company
13F
5.5%
$21,728,416
15,631,954 shares
31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
147
Shares
257,684,976
Rows available
147
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
124
Q2 2025 holders
147
Holder diff
23
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .